Updated Date:
06 Aug 2025
Product Detail:
RUBIFEN LA methylphenidate hydrochloride 40 mg modified release capsules blister pack
Shortage Status:
Current
AUST R:
362230
Availability:
Unavailable
Active Ingredient:
methylphenidate hydrochloride
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Dosage Form:
Capsule,hard
Supply Impact Dates
From 13 May 2025
To 15 Dec 2025
Management Action:
Patients are advised to consult their healthcare professional to discuss their options. Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
